A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer
Simple Summary
- Supplementary File 1:
ZIP-Document (ZIP, 460 KiB)
Salminen, L.; Braicu, E.I.; Lääperi, M.; Jylhä, A.; Oksa, S.; Hietanen, S.; Sehouli, J.; Kulbe, H.; Bois, A.d.; Mahner, S.; Harter, P.; Carpén, O.; Huhtinen, K.; Hynninen, J.; Hilvo, M. A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer. Cancers 2021, 13, 1764. https://doi.org/10.3390/cancers13081764
Salminen L, Braicu EI, Lääperi M, Jylhä A, Oksa S, Hietanen S, Sehouli J, Kulbe H, Bois Ad, Mahner S, Harter P, Carpén O, Huhtinen K, Hynninen J, Hilvo M. A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer. Cancers. 2021; 13(8):1764. https://doi.org/10.3390/cancers13081764
Chicago/Turabian StyleSalminen, Liina, Elena I. Braicu, Mitja Lääperi, Antti Jylhä, Sinikka Oksa, Sakari Hietanen, Jalid Sehouli, Hagen Kulbe, Andreas d. Bois, Sven Mahner, Philipp Harter, Olli Carpén, Kaisa Huhtinen, Johanna Hynninen, and Mika Hilvo. 2021. "A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer" Cancers 13, no. 8: 1764. https://doi.org/10.3390/cancers13081764